Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment

Drug and Alcohol Dependence

Volumn 71, Issue 2, 2003, Pages 207-211

  Aharonovich, Efrat ^a,c   Nunes, Edward ^a,c   Hasin, Deborah ^a,b,c  

^a Columbia University ^*  (United States)

^b New York State Psychiatric Institute ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

CBT; Cocaine; Cognitive impairment; Retention; Treatment

Indexed keywords

COCAINE; GABAPENTIN;

ARTICLE; ATTENTION; BEHAVIOR THERAPY; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RETENTION; DRUG WITHDRAWAL; HUMAN; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT OUTCOME;

EID: 0142012001     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00092-9     Document Type: Article

References (18)

1. Ardila A., Rosselli M., Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int. J. Neurosci. 57:1991;73-79.
2. Berry J., Van Gorp W.G., Herzberg D.S., Hinkin C., Boone K., Steinman L., Wilkins J.N. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend. 32:1993;231-237.
3. Bolla K.I., Rothman R., Cadet J.L. Dose-related neurobehavioral effects of chronic cocaine use. J. Neuropsychiatry Clin. Neurosci. 11:1999;361-369.
4. Bolla K.I., Funderburk F.R., Cadet J.L. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology. 54:2000;2285-2292.
5. Carroll, K.M., 1998. A Cognitive-Behavioral Approach: treating cocaine addiction. Therapy manuals for drug addiction, Rockville, MD: National Institute of Drug Abuse.
6. Carroll K.M., Rounsaville B.J., Gordon L.T., Nich C., Jatlow P., Bisighini R.M., Gawin F.H. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch. Gen. Psychiatry. 51:1994;177-187.
7. Carroll K.M., Rounsaville B.J., Gawin F.H. A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am. J. Drug Alcohol Abuse. 17:1991;229-247.
8. Di Sclafani V., Tolou-Shams M., Price L.J., Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend. 66:2002;161-171.
9. Fals-Stewart W., Schafer J. The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. J. Clin. Psychol. 48:1992;539-543.
10. Harrington D.E., Schwartz S.H., Dailey K. Computerized cognitive assessment of persons with acquired brain injury utilizing MicroCog. Arch. Clin. Neuropsychol. 16:2001;752.
11. Horner M.D. Cognitive functioning in alcoholic patients with and without cocaine dependence. Arch. Clin. Neuropsychol. 12:1997;667-676.
12. Klein D.F. Improvements of Phase III psychotropic drug trials by intensive Phase II work. Neuropsychopharmacol. 4:1991;251-258.
13. Lopez S.J., Ryan J.J., Sumerall S.W., Lichtenberg J.W., Glasnapp D., Krieshok T.S., Van Fleet J.N. Demographic variables and microCog performance: relationships for VA patients under treatment for substance abuse. Psychol. Rep. 88:2001;183-188.
14. Maude-Griffin P.M., Hohenstein J.M., Humfleet G.L., Reilly P.M., Tusel D.J., Hall S.M. Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J. Consult Clin. Psychol. 66:1998;832-837.
15. Nunes, E.V., 1997. Methodological recommendations for cocaine abuse clinical trials: a Clinician-researcher's perspective, Rockville MD, National Institute of Drug Abuse; NIDA Research Monograph 175, pp. 73-95.
16. Powell, D.H., Kaplan, E.F., Whitla, D., Catlin, R., Funkenstein, H.H., 1993. Microcog: Assessment of Cognitive Functioning version 2.1, The Psychological Corporation, San Antonio, TX.
17. Smigielski J.S., Doss R.C. MicroCog: use in an impatient substance abuse treatment setting. Arch. Clin. Neuropsychol. 13:1998;65-66.
18. Teichner G., Horner M.D., Harvey R.T. Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. Int. J. Neurosci. 106:2001;253-263.